The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Practical techniques help minimize crypto drawdown by limiting exposure, timing exits, and balancing risk across assets.
11,804 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
AT&T's AI-driven customer app sparked a notable move in the stock market today, march, as investors weigh tech-enable...
A notable shift is underway in agribusiness investing. Funds are placing sizable bets on agriculture stocks, signalin...
Gold is leading gains in early 2026, while silver remains volatile. Analysts say the evolving ETF landscape is paving...
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Tim Cook used the China Development Forum to stress collaboration with Chinese partners as Beijing intensifies policy...
Figma stock has fallen in 2026 as AI-powered competitors gain ground. This guide breaks down whether the decline crea...
The Federal Reserve just paused rates, signaling a hold as markets weigh the impact on Social Security income and ret...
If you want to trim your monthly costs without a dramatic lifestyle change, you’re not alone. This guide shows practi...
A headline about Palantir and a high-stakes defense AI plan could reshape risk and opportunity. This guide breaks dow...
Intel Arrow Lake Refresh introduces budget-friendly CPUs with stronger cores, bigger caches, and aggressive pricing. ...
Navan stock soared today as the company posted solid growth and highlighted AI-driven efficiencies in its platform. T...